Sign In
Buy JAZZ
$230.93
+4.81 (+2.13%)
At Close: Jun 03, 2026
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of C
4 Discounted PEG Stocks Offering the Best Returns to Value Investors
09:46am, Monday, 10'th Mar 2025
Here we present four discounted PEG stocks that qualify our screening criteria, TAP, BMRN, DVN and JAZZ.
The Zacks Analyst Blog Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals
04:01am, Friday, 07'th Mar 2025
Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals are included in this Analyst Blog.
Jazz Offers to Buy Chimerix for $935M to Boost Oncology Portfolio
10:10am, Thursday, 06'th Mar 2025
JAZZ's acquisition of CMRX is set to add a rare high-grade brain tumor drug currently under the FDA's review. The deal is likely to be closed by June 2024.
Beat Market Volatility With 4 Low-Beta Stocks: PGR, PSO, TXO & JAZZ
09:05am, Thursday, 06'th Mar 2025
It is imperative to build a portfolio of low-beta stocks to navigate a volatile market. PGR, PSO, TXO & JAZZ are well-poised to gain.
3 Highly Ranked Medical Stocks to Buy Amid Recent Market Volatility: JAZZ, OPCH, PCRX,
04:10pm, Wednesday, 05'th Mar 2025
These highly ranked medical stocks have the value and essential services that investors may be looking for as tariff concerns and geopolitical tensions have started to rattle markets.
Jazz Pharma To Buy Chimerix For $935 Million, Strengthening Rare Cancer Pipeline
08:41am, Wednesday, 05'th Mar 2025
On Tuesday, Jazz Pharmaceuticals plc JAZZ agreed to acquire Chimerix Inc CMRX for $8.55 per share in cash, representing a total consideration of approximately $935 million.
Jazz Pharmaceuticals to buy Chimerix for $935 million
07:14am, Wednesday, 05'th Mar 2025
Jazz Pharmaceuticals will acquire biotech firm Chimerix for about $935 million to gain access to its experimental drug to treat a rare brain tumor, the companies said on Wednesday.
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
07:00am, Wednesday, 05'th Mar 2025
-Dordaviprone addresses a significant unmet patient need for patients with rare, high-grade brain tumors- - Transaction to add near-term commercial opportunity to Jazz's pipeline- -Transaction repre
5 Stocks With Recent Price Strength Defying a Weak February
08:31am, Tuesday, 04'th Mar 2025
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are EVER, JAZZ, PGR, SONY, NWG.
Earnings Estimates Moving Higher for Jazz (JAZZ): Time to Buy?
01:20pm, Monday, 03'rd Mar 2025
Jazz (JAZZ) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Wall Street Analysts See a 29.63% Upside in Jazz (JAZZ): Can the Stock Really Move This High?
11:00am, Monday, 03'rd Mar 2025
The consensus price target hints at a 29.6% upside potential for Jazz (JAZZ). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate rev
Best Momentum Stocks to Buy for March 3rd
11:00am, Monday, 03'rd Mar 2025
STRL. BATRA and JAZZ made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 3, 2025.
4 Stocks Trading Near 52-Week High With More Upside Potential
10:46am, Monday, 03'rd Mar 2025
Stocks like NFG, ENS, TAP and JAZZ are seeing price strength and have a high chance of carrying the momentum forward.
New Strong Buy Stocks for March 3rd
08:01am, Monday, 03'rd Mar 2025
Teaser: STRL, CAPL, BATRA, CYD and JAZZ have been added to the Zacks Rank #1 (Strong Buy) List on March 3, 2025.
